Progestins: pro-senescence therapy for ovarian cancer?
作者信息
Oesterreich Steffi, Edwards Robert, Vlad Anda
机构信息
Womens Cancer Research Center, University of Pittsburgh Cancer Institute and Magee-Womens Research Institute; University of Pittsburgh, Pittsburgh, PA USA.
出版信息
Cell Cycle. 2013 Jun 1;12(11):1662-3. doi: 10.4161/cc.25072. Epub 2013 May 17.
Abstract
摘要
相似文献
1
Progestins: pro-senescence therapy for ovarian cancer?孕激素：卵巢癌的促衰老疗法？
Cell Cycle. 2013 Jun 1;12(11):1662-3. doi: 10.4161/cc.25072. Epub 2013 May 17.
2
Progesterone and FOXO1 signaling: harnessing cellular senescence for the treatment of ovarian cancer.孕酮与FOXO1信号传导：利用细胞衰老治疗卵巢癌
Cell Cycle. 2013 Jun 1;12(11):1660-1. doi: 10.4161/cc.25070. Epub 2013 May 17.
3
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.孕激素受体诱导卵巢癌细胞中 FOXO1 依赖性衰老。
Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10.
4
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.活性FOXO1是亚型特异性孕激素受体反式激活和衰老编程的关键决定因素。
Mol Cancer Res. 2016 Feb;14(2):141-62. doi: 10.1158/1541-7786.MCR-15-0431. Epub 2015 Nov 17.
5
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.极光激酶 A/性别决定区 Y 框蛋白 8/叉头框转录因子 K1 信号轴通过抑制卵巢癌细胞球体和细胞衰老及诱导葡萄糖代谢促进化疗耐药性。
Theranostics. 2020 May 25;10(15):6928-6945. doi: 10.7150/thno.43811. eCollection 2020.
6
Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.膜孕激素受体（mPR/PAQR）在卵巢癌细胞中的表达：对孕激素诱导的信号事件的影响。
Horm Cancer. 2010 Aug;1(4):167-76. doi: 10.1007/s12672-010-0023-9.
7
Thioredoxin 1 upregulates FOXO1 transcriptional activity in drug resistance in ovarian cancer cells.硫氧还蛋白1上调卵巢癌细胞耐药中的FOXO1转录活性。
Biochim Biophys Acta. 2015 Mar;1852(3):395-405. doi: 10.1016/j.bbadis.2014.12.002. Epub 2014 Dec 5.
8
Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.叉头转录因子叉头框O1A与孕激素受体之间的转录相互作用协调人子宫内膜基质细胞的细胞周期调控和分化。
Mol Endocrinol. 2007 Oct;21(10):2334-49. doi: 10.1210/me.2007-0058. Epub 2007 Jul 3.
9
Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.叉头转录因子 FOXO1 是孕激素抑制子宫内膜上皮细胞生长的直接靶标。
Clin Cancer Res. 2011 Feb 1;17(3):525-37. doi: 10.1158/1078-0432.CCR-10-1287. Epub 2010 Dec 3.
10
The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.孕激素依赖的 FOXO1/IGFBP-1 轴对于孕激素抑制子宫内膜上皮生长是必需的。
Cancer Lett. 2013 Aug 9;336(1):68-75. doi: 10.1016/j.canlet.2013.04.010. Epub 2013 Apr 18.
引用本文的文献
1
ITPKA induces cell senescence, inhibits ovarian cancer tumorigenesis and can be downregulated by miR-203.ITPKA 诱导细胞衰老，抑制卵巢癌发生，其表达可被 miR-203 下调。
Aging (Albany NY). 2021 Apr 20;13(8):11822-11832. doi: 10.18632/aging.202880.
本文引用的文献
1
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.孕激素受体诱导卵巢癌细胞中 FOXO1 依赖性衰老。
Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10.
2
Hormone response in ovarian cancer: time to reconsider as a clinical target?卵巢癌中的激素反应：是否应重新考虑将其作为临床靶点？
Endocr Relat Cancer. 2012 Nov 9;19(6):R255-79. doi: 10.1530/ERC-12-0175. Print 2012 Dec.
3
Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy.化疗和放疗产生肿瘤疫苗样效应的先决条件。
Cancer J. 2011 Sep-Oct;17(5):351-8. doi: 10.1097/PPO.0b013e3182325d4d.
4
Senescence-messaging secretome: SMS-ing cellular stress.衰老信息分泌组：传递细胞应激信号
Nat Rev Cancer. 2009 Feb;9(2):81-94. doi: 10.1038/nrc2560. Epub 2009 Jan 9.
5
Hormonal therapy in ovarian cancer.卵巢癌的激素治疗
Int J Gynecol Cancer. 2007 Mar-Apr;17(2):325-38. doi: 10.1111/j.1525-1438.2006.00749.x.
6
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.孕激素受体在卵巢癌中的功能及其受雌激素的调节
Clin Cancer Res. 1998 Sep;4(9):2245-51.
Zotero 插件